Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125311441 | 12531144 | 1 | I | 201512 | 20160624 | 20160706 | 20160706 | EXP | FR-APOPHARMA-2016AP009661 | APOTEX | 32.00 | YR | F | Y | 0.00000 | 20160706 | CN | SE | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125311441 | 12531144 | 1 | PS | FERRIPROX | DEFERIPRONE | 1 | Y | 21825 | TABLET | ||||||||||
125311441 | 12531144 | 2 | SS | SIKLOS | HYDROXYUREA | 1 | Y | U | 0 | ||||||||||
125311441 | 12531144 | 3 | SS | DESFERAL | DEFEROXAMINE MESYLATE | 1 | Y | U | 0 | ||||||||||
125311441 | 12531144 | 4 | SS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | 0 | ||||||||||||
125311441 | 12531144 | 5 | SS | TAVANIC | LEVOFLOXACIN | 1 | 0 | ||||||||||||
125311441 | 12531144 | 6 | C | LAROXYL | AMITRIPTYLINE | 1 | U | 0 | |||||||||||
125311441 | 12531144 | 7 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | U | 0 | |||||||||||
125311441 | 12531144 | 8 | C | SPECIAFOLDINE | FOLIC ACID | 1 | U | 0 | |||||||||||
125311441 | 12531144 | 9 | C | BIPROFENID | KETOPROFEN | 1 | U | 0 | |||||||||||
125311441 | 12531144 | 10 | C | TOPALGIC /00599202/ | TRAMADOL | 1 | U | 0 | |||||||||||
125311441 | 12531144 | 11 | C | LAMALINE /00764901/ | ACETAMINOPHENBELLADONNA LEAFCAFFEINEMORPHINE | 1 | U | 0 | |||||||||||
125311441 | 12531144 | 12 | C | INORIAL | BILASTINE | 1 | U | 0 | |||||||||||
125311441 | 12531144 | 13 | C | COVERSYL /00790703/ | PERINDOPRIL | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125311441 | 12531144 | 1 | Sickle cell anaemia |
125311441 | 12531144 | 2 | Product used for unknown indication |
125311441 | 12531144 | 3 | Product used for unknown indication |
125311441 | 12531144 | 4 | Infection |
125311441 | 12531144 | 5 | Infection |
125311441 | 12531144 | 6 | Product used for unknown indication |
125311441 | 12531144 | 7 | Arthritis |
125311441 | 12531144 | 8 | Product used for unknown indication |
125311441 | 12531144 | 9 | Product used for unknown indication |
125311441 | 12531144 | 10 | Product used for unknown indication |
125311441 | 12531144 | 11 | Product used for unknown indication |
125311441 | 12531144 | 12 | Product used for unknown indication |
125311441 | 12531144 | 13 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125311441 | 12531144 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125311441 | 12531144 | Asthenia | |
125311441 | 12531144 | Epistaxis | |
125311441 | 12531144 | Pancytopenia | |
125311441 | 12531144 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |